Report cover image

Hospital Acquired Infection Control Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

Publisher Persistence Research & Consultancy Services
Published Apr 02, 2026
Length 178 Pages
SKU # PERR21067720

Description

Persistence Market Research has recently released a comprehensive report on the global Hospital Acquired Infection Control Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:
  • Hospital Acquired Infection Control Market Size (2025E): US$ 20.6 Bn
  • Projected Market Value (2032F): US$ 32.9 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.9%
Hospital Acquired Infection Control Market - Report Scope:

The hospital acquired infection control market focuses on products, services, and solutions aimed at preventing and managing infections that patients acquire during hospital stays or healthcare procedures. These infections include bloodstream infections, surgical site infections, pneumonia, and urinary tract infections. The market comprises a wide range of solutions such as sterilization equipment, disinfection products, protective barriers, and endoscope reprocessing systems. The increasing emphasis on patient safety, stringent healthcare regulations, and the need for effective infection prevention strategies are driving the demand for advanced infection control solutions across healthcare facilities.

Market Growth Drivers:

The global hospital acquired infection control market is witnessing steady growth driven by the rising prevalence of hospital-acquired infections (HAIs) and increasing awareness regarding infection prevention in healthcare settings. The growing adoption of advanced sterilization technologies and automated disinfection systems is significantly enhancing infection control efficiency. Additionally, the expansion of healthcare infrastructure, particularly in emerging economies, and the increasing number of surgical procedures are further contributing to market growth. Government initiatives and regulatory mandates promoting hygiene standards and patient safety are also playing a crucial role in boosting the adoption of infection control solutions.

Market Restraints:

Despite favorable growth prospects, the hospital acquired infection control market faces several challenges, including the high cost associated with advanced sterilization and disinfection equipment, which may limit adoption in resource-constrained healthcare facilities. Lack of proper training and awareness among healthcare professionals regarding infection control practices can also hinder effective implementation. Furthermore, concerns related to the safety and environmental impact of certain disinfectants and sterilization agents may restrict their usage and pose regulatory challenges.

Market Opportunities:

The hospital acquired infection control market presents significant opportunities with the increasing integration of automation and digital technologies in healthcare settings. The development of innovative and eco-friendly disinfection solutions, along with advancements in ultraviolet (UV) and hydrogen peroxide-based sterilization technologies, is expected to create new growth avenues. Emerging markets in Asia-Pacific and Latin America offer substantial potential due to improving healthcare infrastructure and rising investments in hospital facilities. Additionally, the growing focus on outpatient and ambulatory surgical centers is expected to drive demand for portable and cost-effective infection control solutions.

Key Questions Answered in the Report:
  • What are the primary factors driving the global hospital acquired infection control market's growth?
  • Which regions and market segments are experiencing the highest demand for infection control solutions?
  • How are technological advancements influencing infection prevention strategies?
  • Who are the key players in the hospital acquired infection control market, and what strategies are they adopting to stay competitive?
  • What are the emerging trends and future projections for the global hospital acquired infection control market?
Competitive Intelligence and Business Strategy:

Leading companies in the global hospital acquired infection control market are focusing on technological advancements, product innovation, and strategic collaborations to strengthen their market position. These players are investing in research and development to introduce more efficient and safer sterilization and disinfection solutions. Partnerships with healthcare providers and expansion of distribution networks are enabling companies to enhance their global footprint. Additionally, emphasis on automation and environmentally sustainable products is helping companies gain a competitive edge in the evolving healthcare landscape.

Companies Covered in This Report:
  • Belimed Inc.
  • The 3M Company
  • ASP (Advanced Sterilization Products Services, Inc.)
  • Getinge AB
  • O&M Halyards
  • Sterigenics U.S., LLC - A Sotera Health Company
  • Midmark Corporation
  • MMM Group
  • Steris plc
  • Midmark Corporati
Market Segmentation

By Infection Type
  • Bloodstream Infections
  • Hospital-acquired Pneumonia
  • Gastrointestinal Infections
  • Surgical Site Infections
  • UTIs
  • Others
By Products and Services
  • Protective Barriers
  • Cleaning and Disinfection Products
  • Sterilization
  • Endoscope Reprocessing Products
By End-user
  • Surgical Centers
  • Hospitals and Clinics
  • Others
By Region
  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa


Please Note: It will take 5 business days to complete the report upon order confirmation.

Table of Contents

178 Pages
1. Executive Summary
1.1. Global Hospital Acquired Infection Control Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. COVID-19 Impact Analysis
2.4. Forecast Factors - Relevance and Impact
3. Value Chain Analysis
3.1. Supply Chain Analysis
3.2. List of Key Market Players
4. Value Added Insights
4.1. PESTLE Analysis
4.2. Porter’s Five Force Analysis
5. Price Trend Analysis, 2019 - 2032
5.1. Pricing Analysis, By Infection Type
5.2. Key Factors Impacting Prices, By Products and Services
6. Global Hospital Acquired Infection Control Market Outlook
6.1. Key Highlights
6.1.1. Market Size (US$ Bn) and Y-o-Y Growth
6.1.2. Absolute $ Opportunity
6.2. Market Size (US$ Bn) Analysis and Forecast
6.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
6.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
6.3. Global Hospital Acquired Infection Control Market Outlook: Infection Type
6.3.1. Historical Market Size (US$ Bn) Analysis, By Infection Type, 2019-2024
6.3.2. Market Size (US$ Bn) Analysis and Forecast, By Infection Type, 2025-2032
6.3.2.1. Bloodstream Infections
6.3.2.2. Hospital-acquired Pneumonia
6.3.2.3. Gastrointestinal Infections
6.3.2.4. Surgical Site
6.3.2.5. UTIs
6.3.2.6. Others
6.3.3. Market Attractiveness Analysis: Infection Type
6.4. Global Hospital Acquired Infection Control Market Outlook: Products and Services
6.4.1. Historical Market Size (US$ Bn) Analysis, By Products and Services, 2019-2024
6.4.2. Market Size (US$ Bn) Analysis and Forecast, By Products and Services, 2025-2032
6.4.2.1. Protective Barriers
6.4.2.2. Cleaning and Disinfection Products
6.4.2.3. Sterilization
6.4.2.4. Endoscope Reprocessing Products
6.4.3. Market Attractiveness Analysis: Products and Services
6.5. Global Hospital Acquired Infection Control Market Outlook: End-user
6.5.1. Historical Market Size (US$ Bn) Analysis, By End-user, 2019-2024
6.5.2. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
6.5.2.1. Surgical Centers
6.5.2.2. Hospitals and Clinics
6.5.2.3. Others
6.5.3. Market Attractiveness Analysis: End-user
7. Global Hospital Acquired Infection Control Market Outlook: Region
7.1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
7.2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
7.2.1. North America
7.2.2. Europe
7.2.3. East Asia
7.2.4. South Asia and Oceania
7.2.5. Latin America
7.2.6. Middle East & Africa
7.3. Market Attractiveness Analysis: Region
8. North America Hospital Acquired Infection Control Market Outlook
8.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
8.1.1. By Country
8.1.2. By Infection Type
8.1.3. By Products and Services
8.1.4. By End-user
8.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
8.2.1. U.S.
8.2.2. Canada
8.3. Market Size (US$ Bn) Analysis and Forecast, By Infection Type, 2025-2032
8.3.1. Bloodstream Infections
8.3.2. Hospital-acquired Pneumonia
8.3.3. Gastrointestinal Infections
8.3.4. Surgical Site
8.3.5. UTIs
8.3.6. Others
8.4. Market Size (US$ Bn) Analysis and Forecast, By Products and Services, 2025-2032
8.4.1. Protective Barriers
8.4.2. Cleaning and Disinfection Products
8.4.3. Sterilization
8.4.4. Endoscope Reprocessing Products
8.5. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
8.5.1. Surgical Centers
8.5.2. Hospitals and Clinics
8.5.3. Others
8.6. Market Attractiveness Analysis
9. Europe Hospital Acquired Infection Control Market Outlook
9.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
9.1.1. By Country
9.1.2. By Infection Type
9.1.3. By Products and Services
9.1.4. ByEnd-user
9.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
9.2.1. Germany
9.2.2. France
9.2.3. U.K.
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Turkey
9.2.8. Rest of Europe
9.3. Market Size (US$ Bn) Analysis and Forecast, By Infection Type, 2025-2032
9.3.1. Bloodstream Infections
9.3.2. Hospital-acquired Pneumonia
9.3.3. Gastrointestinal Infections
9.3.4. Surgical Site
9.3.5. UTIs
9.3.6. Others
9.4. Market Size (US$ Bn) Analysis and Forecast, By Products and Services, 2025-2032
9.4.1. Protective Barriers
9.4.2. Cleaning and Disinfection Products
9.4.3. Sterilization
9.4.4. Endoscope Reprocessing Products
9.5. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
9.5.1. Surgical Centers
9.5.2. Hospitals and Clinics
9.5.3. Others
9.6. Market Attractiveness Analysis
10. East Asia Hospital Acquired Infection Control Market Outlook
10.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
10.1.1. By Country
10.1.2. By Infection Type
10.1.3. By Products and Services
10.1.4. By End-user
10.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.3. Market Size (US$ Bn) Analysis and Forecast, By Infection Type, 2025-2032
10.3.1. Bloodstream Infections
10.3.2. Hospital-acquired Pneumonia
10.3.3. Gastrointestinal Infections
10.3.4. Surgical Site
10.3.5. UTIs
10.3.6. Others
10.4. Market Size (US$ Bn) Analysis and Forecast, By Products and Services, 2025-2032
10.4.1. Protective Barriers
10.4.2. Cleaning and Disinfection Products
10.4.3. Sterilization
10.4.4. Endoscope Reprocessing Products
10.5. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
10.5.1. Surgical Centers
10.5.2. Hospitals and Clinics
10.5.3. Others
10.6. Market Attractiveness Analysis
11. South Asia & Oceania Hospital Acquired Infection Control Market Outlook
11.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
11.1.1. By Country
11.1.2. By Infection Type
11.1.3. By Products and Services
11.1.4. By End-user
11.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
11.2.1. India
11.2.2. Southeast Asia
11.2.3. ANZ
11.2.4. Rest of South Asia & Oceania
11.3. Market Size (US$ Bn) Analysis and Forecast, By Infection Type, 2025-2032
11.3.1. Bloodstream Infections
11.3.2. Hospital-acquired Pneumonia
11.3.3. Gastrointestinal Infections
11.3.4. Surgical Site
11.3.5. UTIs
11.3.6. Others
11.4. Market Size (US$ Bn) Analysis and Forecast, By Products and Services, 2025-2032
11.4.1. Protective Barriers
11.4.2. Cleaning and Disinfection Products
11.4.3. Sterilization
11.4.4. Endoscope Reprocessing Products
11.5. Market Size (US$ Bn) Analysis and Forecast, ByEnd-user, 2025-2032
11.5.1. Surgical Centers
11.5.2. Hospitals and Clinics
11.5.3. Others
11.6. Market Attractiveness Analysis
12. Latin America Hospital Acquired Infection Control Market Outlook
12.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
12.1.1. By Country
12.1.2. By Infection Type
12.1.3. By Products and Services
12.1.4. By End-user
12.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
12.2.1. Brazil
12.2.2. Mexico
12.2.3. Rest of Latin America
12.3. Market Size (US$ Bn) Analysis and Forecast, By Infection Type, 2025-2032
12.3.1. Bloodstream Infections
12.3.2. Hospital-acquired Pneumonia
12.3.3. Gastrointestinal Infections
12.3.4. Surgical Site
12.3.5. UTIs
12.3.6. Others
12.4. Market Size (US$ Bn) Analysis and Forecast, By Products and Services, 2025-2032
12.4.1. Protective Barriers
12.4.2. Cleaning and Disinfection Products
12.4.3. Sterilization
12.4.4. Endoscope Reprocessing Products
12.5. Market Size (US$ Bn) Analysis and Forecast, ByEnd-user, 2025-2032
12.5.1. Surgical Centers
12.5.2. Hospitals and Clinics
12.5.3. Others
12.6. Market Attractiveness Analysis
13. Middle East & Africa Hospital Acquired Infection Control Market Outlook
13.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
13.1.1. By Country
13.1.2. By Infection Type
13.1.3. By Products and Services
13.1.4. By End-user
13.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
13.2.1. GCC Countries
13.2.2. Egypt
13.2.3. South Africa
13.2.4. Northern Africa
13.2.5. Rest of Middle East & Africa
13.3. Market Size (US$ Bn) Analysis and Forecast, By Infection Type, 2025-2032
13.3.1. Bloodstream Infections
13.3.2. Hospital-acquired Pneumonia
13.3.3. Gastrointestinal Infections
13.3.4. Surgical Site
13.3.5. UTIs
13.3.6. Others
13.4. Market Size (US$ Bn) Analysis and Forecast, By Products and Services, 2025-2032
13.4.1. Protective Barriers
13.4.2. Cleaning and Disinfection Products
13.4.3. Sterilization
13.4.4. Endoscope Reprocessing Products
13.5. Market Size (US$ Bn) Analysis and Forecast, ByEnd-user, 2025-2032
13.5.1. Surgical Centers
13.5.2. Hospitals and Clinics
13.5.3. Others
13.6. Market Attractiveness Analysis
14. Competition Landscape
14.1. Market Share Analysis, 2025
14.2. Market Structure
14.2.1. Competition Intensity Mapping By Market
14.2.2. Competition Dashboard
14.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
14.3.1. Belimed Inc.
14.3.1.1. Overview
14.3.1.2. Segments and Infection Type
14.3.1.3. Key Financials
14.3.1.4. Market Developments
14.3.1.5. Market Strategy
14.3.2. The 3M Company
14.3.3. ASP (Advanced Sterilization Products Services, Inc.)
14.3.4. Getinge AB
14.3.5. O&M Halyards
14.3.6. Sterigenics U.S., LLC - A Sotera Health Company
14.3.7. Midmark Corporation
14.3.8. MMM Group
14.3.9. Steris plc
14.3.10. Midmark Corporation
14.3.11. W&H (UK) Ltd.
14.3.12. Others
15. Appendix
15.1. Research Methodology
15.2. Research Assumptions
15.3. Acronyms and Abbreviations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us